QUANTITATIVE MASSIV PARALLELE PROTEOMIK

Patent europeic · EP3488239 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3488239
Numer da la dumonda
EP17748996
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
21-07-2017
Publitgà
29-05-2019
Concedì
25-03-2026
La protecziun finescha il pli tard
20-07-2037
Proxima taxa annuala scadenta
31-07-2026
Classas IPC
C12Q 1/6804 (2018.01)
G01N 33/58 (2006.01)
C12Q 1/68 (2018.01)
Prioritad
US 201662365542 P 22.07.2016
Dumonda PCT
PCT/US2017/043273 21.07.2017
Publicaziun PCT
WO2018/017949 25.01.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-04-2026

    Owner

    Owner
    Verily Life Sciences LLC, 2999 Olympus Blvd, 10th Floor / Ste 1000, Dallas, TX 75019, USA → Verily Health Inc., 2999 Olympus Blvd, 10th Floor, Ste 1000, Dallas, Texas 75019, USA

    Published in Swissreg on 23.04.2026

  2. 25-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.03.2026

Partidas

Possessur

Verily Health Inc.

2999 Olympus Blvd 10th Floor, Ste 1000, Dallas, Texas 75019, US

Inventur

PEIKON, Ian

Bethpage, NY 11714, US

TONG, Gary

South San Francisco, CA 94080, US

LIU, Daniel

South San Francisco, CA 94080, US

CHU, Ci

South San Francisco, CA 94080, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.